AFCR SUPPORTS various types of cancer and stages of research including basic, translational and clinical.
As we celebrate this remarkable 20-year milestone, we honor the dedication of scientists, donors, and partners who have made these achievements possible.
The future holds even greater promise as AFCR continues its mission to conquer cancer through research, compassion, and global unity.
Early Detection & Prevention
- Identify Biomarkers for Risk of Colorectal Cancer Metastasis 2010—2012
- Identify Biomarkers of Esophageal Cancer: Early Detection Screen Test 2013—2015
- New Models of Cancer Development Can Lead to Prevention Tools 2014—2019
- Detecting Hereditary Breast & Ovarian Cancer in China 2018—2020
- Improving Detection of Early Esophageal Cancer 2018—Present
- Loco-regional Delivery of Drugs toPrevent Cancer from Abnormal Cells 2021—Present
Diagnostic Technologies
- Improved Ultrasound for Accurate Esophageal Cancer Diagnosis 2018—Present
Innovative Therapies & Treatments
- Merging Western Science and Traditional Chinese Medicine—Botanical Cancer Drug Platform 2010—Present
- Personalized Medicine For Non-Small Cell Lung Cancer 2010—2011
- Biomarkers as New Targets to Develop Novel Therapies for Colorectal Cancer Metastasis 2010—2012
- Powerful microRNAs Overcome Chemotherapy Resistance in Ovarian Cancer 2013—2014
- Biomarker May Be A Novel Tumor Suppressor Gene in Colorectal Cancer 2013—2014
- Biomarkers of Esophageal Cancer for Therapeutic Targets 2013—2015
- Mapping the Gastric Cancer Genome for Personal Treatment 2013—2016
- New Models of Cancer Development: Can Lead to More Effective Treatments 2014—2019
- Role of Cell Polarity Proteins in Epithelial Cancers Ending Drug Resistance to Major Cancer Pathway 2017—Present
- An Innovative Treatment for Liver Cancer 2018—Present
- Develop Guide to Treat Hereditary Breast & Ovarian Cancer in China 2018—2020
- Multi-functional Antibodies: Targeting Cancer on Multiple Fronts 2020—Present
- Engaging the Immune System to Treat Gastrointestinal Cancers 2020—Present
- Safer, More Effective CAR-T Cell Therapies 2021—Present
- Nano-Engineered Technology: Paradigm-changing Treatment For Oral Cancers 2021—Present
- Loco-regional Delivery of Drugs Post Surgery to Eliminate Residual Cancer Cells 2021—Present
- Molecular Glue Degraders: Targeting Undruggable Cancer Targets 2023—Presentive Treatments 2014—2019
- Revolutionary Drug Delivery Platform: Improves Treatment Effectiveness and Tolerability 2021—Present
- Novel Antibodies to Activate Anti-Tumor Responses 2021—Present
Global Collaborative Platforms
- Tissue Bank Consortium in Asia: Provides and facilitates biospecimenbased global cancer research collaboration 2013—2016
- Global Clinical Trial Allows More Brain Cancer Patients to Quickly Receive Promising Treatments 2014—Present
